Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia

MeSH terms

• Adult
• Antineoplastic Agents / administration & dosage*
• Antineoplastic Agents / adverse effects
• Disease-Free Survival
• Dose-Response Relationship, Drug
• Female
• Follow-Up Studies
• Humans
• Imatinib Mesylate / administration & dosage
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
• Male
• Protein Kinase Inhibitors / administration & dosage*
• Protein Kinase Inhibitors / adverse effects
• Protein-Tyrosine Kinases / antagonists & inhibitors*
• Pyrimidines / administration & dosage
• Pyrimidines / adverse effects
• Withholding Treatment*